Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5

scientific article published on 01 November 2014

Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5 is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID25362221

P2093author name stringFarshid Haghverdi
Parvin Soltani
Sepideh Mortaji
Naser Saidi
Tahmineh Farbodara
P433issue6
P921main subjectchronic renal insufficiencyQ736715
P304page(s)461-466
P577publication date2014-11-01
P1433published inIranian journal of kidney diseasesQ26842106
P1476titleEffect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5
P478volume8

Reverse relations

cites work (P2860)
Q57452989Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis
Q39255870Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
Q36823369Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease

Search more.